The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Reading Rheum

Reading Rheum

February 1, 2008 • By Maripat Corr, MD; Daniel Hal Solomon, MD, MPH

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Ankylosing Spondylitis

Gene Association Hints at Potential Ankylosing Spondylitis Treatment

By Maripat Corr, MD

You Might Also Like
  • Reading Rheum
  • Reading Rheum: Which Bone Agent Is Best in High-risk Osteoporosis?
  • Reading Rheum

Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39(11):1329-1337.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Abstract

We have genotyped 14,436 nonsynonymous single nucleotide polymorphisms (nsSNPs) and 897 major histocompatibility complex (MHC) tag SNPs from 1,000 independent cases of ankylosing spondylitis (AS), autoimmune thyroid disease (AITD), multiple sclerosis (MS), and breast cancer (BC). Comparing these data against a common control dataset derived from 1,500 randomly selected healthy British individuals, we report initial association and independent replication in a North American sample of two new loci related to AS—ARTS1 and IL23R—and confirmation of the previously reported association of AITD with TSHR and FCRL3. These findings, enabled in part by increased statistical power resulting from the expansion of the control reference group to include individuals from the other disease groups, highlight notable new possibilities for autoimmune regulation and suggest that IL23R may be a common susceptibility factor for the major “seronegative” diseases.

Commentary

The new platforms for high-throughput genetic screening are rapidly expanding our knowledge of susceptibility loci for complex diseases. Investigators for the Wellcome Trust Case Control Consortium and the Australo-Anglo-American Spondylitis Consortium recently reported their findings from a large, genome-wide scan of four diseases. The strongest associations observed in the study were between SNPs in the major histocompatibility (MHC) encoding region and the three autoimmune diseases studied: AS, AITD, and MS. The genome-wide scan also identified and validated two new genes—ARTS1 (type 1 tumor necrosis factor receptor shedding aminopeptidase regulator) and IL23R (interleukin 23 receptor)—to be associated with AS.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Functionally, ARTS1 and IL23R represent interesting biological candidates for association with AS. The ARTS1 (also known as ERAAP, or ERAP1) gene encodes a type II integral transmembrane aminopeptidase with intra- and extracellular functions. In the endoplasmic reticulum, ARTS1 is involved in processing peptides to the optimal length for MHC class I presentation.1,2 This activity is intriguing because of the strong association of AS with the class I allele HLA-B27. A genetic association with the peptide loading process suggests a mechanistic link to HLA-B27 in developing disease. Alternatively, ARTS1 cleaves cell surface receptors for pro-inflammatory cytokines like IL-1, IL-6, and tumor necrosis factor (TNF), reducing the number of surface receptors and releasing soluble receptor antagonists.3-5 Potentially, a variant of ARTS1 with reduced ability to cleave surface receptors would prolong the interval that cells could receive signals from inflammatory cytokines.

Pages: 1 2 3 4 | Single Page

Filed Under: Research Reviews, Spondyloarthritis Tagged With: Ankylosing Spondylitis, Practice tools, Treatment

You Might Also Like:
  • Reading Rheum
  • Reading Rheum: Which Bone Agent Is Best in High-risk Osteoporosis?
  • Reading Rheum
  • Reading Rheum

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.